Navigation Links
VirtualScopics Reports First Quarter 2013 Results
Date:5/15/2013

ualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images.  In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster.  For more information about VirtualScopics, visit www.virtualscopics.com.

Forward-Looking Statements
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby. These forward-looking statements include, but are not limited to, statements regarding the expected benefits of the Company's investment in infrastructure and new customer contract signings and awards and/or statements preceded by, followed by or that include the words "believes," "could," "expects," "anticipates," "estimates," "intends," "plans," "projects," "seeks," or similar expressions. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations. Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements.  Many of these risks and uncertainties are discussed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed with the Securities and Exchange Commission (the "SEC"), and in any subsequent reports filed with the SEC, all of which are available at the SEC's website at www.sec.gov. These include without limitation:
'/>"/>

SOURCE VirtualScopics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. VirtualScopics Schedules Second Quarter 2012 Earnings Announcement
2. VirtualScopics Reports 2nd Quarter 2012 Results
3. VirtualScopics Announces Receipt of Notice from Nasdaq
4. VirtualScopics to Present at the Upcoming Rodman & Renshaw Annual Global Investment Conference
5. VirtualScopics Receives Issuance of Influential Patent in Canada
6. VirtualScopics Reports 3rd Quarter 2012 Results
7. VirtualScopics Schedules Fourth Quarter and Full Year 2012 Earnings Announcement
8. VirtualScopics Reports Fourth-Quarter and Full-Year 2012 Results
9. VirtualScopics Receives Additional Time to Regain Compliance with Nasdaq
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
(Date:1/15/2014)... 15, 2014 Shire plc (LSE: SHP, NASDAQ: ... Fair Trading (OFT) approval condition to the announced tender offer for ... As a result of the waiver, the transaction is ... the tender offer on January 24, 2014 following the currently scheduled ...
(Date:1/15/2014)... 2014 Tegra Medical is very pleased to announce the ... new Chief Executive Officer.  Mark was promoted from his current ... the company,s four facilities in Massachusetts , ... joined Tegra Medical in 2012 with 20+ years of broad-based ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Oct. 16 AngioGenex Inc. (OTC,Bulletin Board: AGGX.OB) ... molecules that are potent inhibitors of the Id ... filing of this patent,constitute major milestones in the ... Dr. Richard Salvador, President and CEO, and the,former ...
... Oct. 16 When eighty-six-year-old,Keith Hora went to see ... University of Newcastle in Australia, he was told he ... been diagnosed with stage III melanoma, one,of the most ... had multiple melanoma reoccurrences in the previously treated,area of ...
Cached Medicine Technology:AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer 2Recipient of Melanoma Drug in Development Celebrates Two Cancer-Free Years 2
(Date:7/9/2014)... ways that cells are regulated, scientists at Rockefeller University ... more likely to metastasize. , What,s more, the protein ... two other proteins that are normally linked to neurodegeneration, ... have unexpected ties. , The study, which appears ... points to the possibility of new cancer therapies that ...
(Date:7/9/2014)... of stromal support cells and immune cells and ... in the development of diseases could open new ... was the conclusion of a review article by scientists ... Nature . , Prof. Peter Carmeliet: "Consider the ... of cancer cells has been examined in minute detail ...
(Date:7/9/2014)... have found that fecal transplantation is effective and safe ... This is the result of a study led by ... Women,s Gastrointestinal Medicine at The Women,s Medicine Collaborative. The ... advance of print in the American Journal of ... C. diff , has increased to epidemic proportions over ...
(Date:7/9/2014)... Researchers from The Miriam Hospital have found that ... are also depressed have difficulty sticking to a ... true for women, and screening and brief treatment ... treatment. The study and its findings are published ... , Chronic obstructive pulmonary disease is a common ...
(Date:7/9/2014)... French . ... teens, including brain structure and function, personality, life experiences and ... on to develop binge drinking within the next two years. ... such as life events and a family history of drug ... or not the child had had a single drink at ...
Breaking Medicine News(10 mins):Health News:Protein pushes breast cancer cells to metastasize 2Health News:Protein pushes breast cancer cells to metastasize 3Health News:Wake-up call for more research into cell metabolism 2Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:Miriam Hospital study examines effect of depressed mood on pulmonary rehab completion 2Health News:What drives a child to abuse alcohol? 2
... Reports of a study reports that married women is having ... men or unmarried women and the report finds out that ... compared to married women. // , ,Catherine Mercer, ... said. "That is, within a relationship, people who were less ...
... health as it induces lot of alterations in the metabolism ... of colorectal tumours, while drinking in moderation lowers the risk, ... was conducted by Joseph C. Anderson, M.D. and colleagues at ... patients were subject to a survey of drinking habits and ...
... high but critics are more concerned with the availability of ... available to the developing and under developed countries//. ... anytime, due to current global conditions, as there are serious ... continue people have started stock piling and storing stocks of ...
... above may have a sedentary lifestyle if they perceive that their ... earlier studies that fewer than 40 percent of adults aged 65 ... years of independent life., ,A new UCLA study found that ... one can do at an advanced age — were the most ...
... University have said they are trying to develop an ... against lung cancer//. , ,Experiments with mice have ... still needed before the new therapy could be used ... ,"In fact it's a paradox," said research scientist Christian ...
... 27: Union Health Minister Anbumani Ramadoss today fired another salvo at ... country. He said: "influence of mafias over such a regulatory body ... MCI is an autonomous body and the government has no say ... in its functioning. , ,He said a cleansing process ...
Cached Medicine News:Health News:Alcohol Consumption A Threat To Colorectal Tumours 2Health News:Flu Vaccine Can Be Used To Treat Lung Cancer 2
Inorganic phosphorus (UV method) reagent is for the quantitative determination of inorganic phosphorus in human serum....
For the quantitative determination of Inorganic Phosphorus in serum. Linearity: 12.0 mg/dl....
For the kinetic quantitative determination of g-Glutamyl Transferase in serum for manual and/or automated procedures....
Intended for the quantitative determination of gammaglutamyl transferase activity in serum or plasma. Single vial, dry powder reagent. Readily soluble at room temperature. Reaction: Kinetic. Waveleng...
Medicine Products: